H_CD274(PD-L1) CHO-K1 Cell Line
Cat. No.
GM-C01115
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C01115
Product H_CD274(PD-L1) CHO-K1 Cell Line
Description H_CD274(PD-L1) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human CD274(PD-L1).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD274(PD-L1)
Gene ID/Uniprot ID Q9NZQ7-1
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C01115
Product H_CD274(PD-L1) CHO-K1 Cell Line
Description H_CD274(PD-L1) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human CD274(PD-L1).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD274(PD-L1)
Gene ID/Uniprot ID Q9NZQ7-1
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_CD274(PD-L1) CHO-K1 Cell Line was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Genomeditech/GM-31740AB).
Stability
The passage stability of the H_CD274(PD-L1) CHO-K1 Cell Line (Genomeditech/GM-C01115) was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Genomeditech/GM-31740AB).
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Genomeditech/GM-31740AB
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Genomeditech/GM-31740AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
PD-1:PD-L1(B7-H1):PDL2
Mouse_PDL1 KO CT26 Cell Line Mouse_PDL1 KO LLC1 Cell Line Mouse_PDL1 KO MC38 Cell Line
aAPC(OKT3) PDL1 CHO-K1 Cell Line H_PD-1 Reporter Jurkat Cell Line H_PD1 SHP1 Reporter Jurkat Cell line
H_PD1 SHP2 Reporter Jurkat Cell Line H_PDCD1LG2(PDL2) aAPC CHO-K1 Cell Line Mouse PDL1 aAPC CHO-K1 Cell Line
Mouse_PD-1 Reporter Jurkat Cell Line Canine_PD-1 CHO-K1 Cell Line Canine_PD-1 HEK-293 Cell Line
Cynomolgus_PD1 CHO-K1 Cell Line Cynomolgus_PD-L1 HEK-293 Cell Line H_CD274(PD-L1) MC38 Cell Line
H_PDCD1(PD-1) CHO-K1 Cell Line H_PDCD1(PD-1) CHO-K1 Cell Line (Low Expression) H_PDCD1(PD-1) HEK-293 Cell Line
H_PDCD1LG2(PDL2) CHO-K1 Cell Line H_PDL1 CT26(mouse PDL1 KO) Cell Line H_PD-L1 HEK-293 Cell Line
H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 MC38(mouse PDL1 KO) Cell Line
H_PD-L1 Raji Cell Line M_PDCD1(PD-1) CHO-K1 Cell Line
Anti-Canine_PD1 mIgG2a Antibody(4F12-E6) Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody(Cadonilimab) Anti-CTLA4×PD-1 hIgG1 Reference Antibody (Cadbio)
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Anti-H_PDCD1(PD1) hIgG1 Antibody(Budigalimab) Anti-H_PDCD1LG2 mIgG1 Antibody(3G2)
Anti-H_PDL1 hIgG1 Reference Antibody(Atezbio) Anti-mouse PD1 RIgG2a Antibody(RMP1-14) Anti-mouse PD-L1 mIgG1 Antibody(10F.9G2)
Anti-Mouse_PD1 mIgG1 Antibody(29F.1A12) Anti-mouse_PD1 mIgG1 Antibody(RMP1-14) Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
Anti-PD1 hIgG1 Antibody(Peresolimab) Anti-PD1 hIgG1 Reference Antibody (Perbio) Anti-PD1 hIgG1 Reference Antibody(Rosnbio)
Anti-PD1 hIgG4 Antibody(Pembrolizumab) Anti-PD1 hIgG4 Reference Antibody (Nivbio) Anti-PD1 hIgG4 Reference Antibody (Pembio)
Anti-PD1 hIgG4 Reference Antibody (Sintbio) Anti-PD-1 hIgG4 Reference Antibody (Torbio) Anti-PD1 hIgG4 Reference Antibody(Cambio)
Anti-PD-1 hIgG4 Reference Antibody(Tislbio) Anti-PD1-IL2v Fusion hIgG1 Antibody(2149) Anti-PD1-IL2v Fusion hIgG1 Antibody(KY-0118)
Anti-PD-L1 hIgG1 Reference Antibody(Avebio) Anti-PDL1 hIgG4 Reference Antibody(Adebio) Anti-PD-L2 hIgG1 Antibody(Hz25G4-1.1)
Anti-VEGF×PD1 hIgG1 Reference Antibody (Ivobio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (Pumibio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (pumitamig)
Biotinylated Human PD1 Protein; His-Avi Tag Biotinylated Human PDL1 Protein; His-Avi Tag Canine PD1 Protein; hFc Tag
Cynomolgus PDL1 Protein; His Tag Human PD1 Protein; hFc Tag Human PD1 Protein; His Tag
Human PDL1 Protein; His Tag Human PDL1 Protein; mFc Tag Human PDL2 Protein; mFc Tag
Mouse PDL1 Protein; His Tag    
H_CD274(PD-L1) CHO-K1 Cell Line
Cat. No.
GM-C01115
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C01115
Product H_CD274(PD-L1) CHO-K1 Cell Line
Description H_CD274(PD-L1) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human CD274(PD-L1).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD274(PD-L1)
Gene ID/Uniprot ID Q9NZQ7-1
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C01115
Product H_CD274(PD-L1) CHO-K1 Cell Line
Description H_CD274(PD-L1) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human CD274(PD-L1).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD274(PD-L1)
Gene ID/Uniprot ID Q9NZQ7-1
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_CD274(PD-L1) CHO-K1 Cell Line was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Genomeditech/GM-31740AB).
Stability
The passage stability of the H_CD274(PD-L1) CHO-K1 Cell Line (Genomeditech/GM-C01115) was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Genomeditech/GM-31740AB).
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Genomeditech/GM-31740AB
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Genomeditech/GM-31740AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
PD-1:PD-L1(B7-H1):PDL2
Mouse_PDL1 KO CT26 Cell Line Mouse_PDL1 KO LLC1 Cell Line Mouse_PDL1 KO MC38 Cell Line
aAPC(OKT3) PDL1 CHO-K1 Cell Line H_PD-1 Reporter Jurkat Cell Line H_PD1 SHP1 Reporter Jurkat Cell line
H_PD1 SHP2 Reporter Jurkat Cell Line H_PDCD1LG2(PDL2) aAPC CHO-K1 Cell Line Mouse PDL1 aAPC CHO-K1 Cell Line
Mouse_PD-1 Reporter Jurkat Cell Line Canine_PD-1 CHO-K1 Cell Line Canine_PD-1 HEK-293 Cell Line
Cynomolgus_PD1 CHO-K1 Cell Line Cynomolgus_PD-L1 HEK-293 Cell Line H_CD274(PD-L1) MC38 Cell Line
H_PDCD1(PD-1) CHO-K1 Cell Line H_PDCD1(PD-1) CHO-K1 Cell Line (Low Expression) H_PDCD1(PD-1) HEK-293 Cell Line
H_PDCD1LG2(PDL2) CHO-K1 Cell Line H_PDL1 CT26(mouse PDL1 KO) Cell Line H_PD-L1 HEK-293 Cell Line
H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 MC38(mouse PDL1 KO) Cell Line
H_PD-L1 Raji Cell Line M_PDCD1(PD-1) CHO-K1 Cell Line
Anti-Canine_PD1 mIgG2a Antibody(4F12-E6) Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody(Cadonilimab) Anti-CTLA4×PD-1 hIgG1 Reference Antibody (Cadbio)
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) Anti-H_PDCD1(PD1) hIgG1 Antibody(Budigalimab) Anti-H_PDCD1LG2 mIgG1 Antibody(3G2)
Anti-H_PDL1 hIgG1 Reference Antibody(Atezbio) Anti-mouse PD1 RIgG2a Antibody(RMP1-14) Anti-mouse PD-L1 mIgG1 Antibody(10F.9G2)
Anti-Mouse_PD1 mIgG1 Antibody(29F.1A12) Anti-mouse_PD1 mIgG1 Antibody(RMP1-14) Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
Anti-PD1 hIgG1 Antibody(Peresolimab) Anti-PD1 hIgG1 Reference Antibody (Perbio) Anti-PD1 hIgG1 Reference Antibody(Rosnbio)
Anti-PD1 hIgG4 Antibody(Pembrolizumab) Anti-PD1 hIgG4 Reference Antibody (Nivbio) Anti-PD1 hIgG4 Reference Antibody (Pembio)
Anti-PD1 hIgG4 Reference Antibody (Sintbio) Anti-PD-1 hIgG4 Reference Antibody (Torbio) Anti-PD1 hIgG4 Reference Antibody(Cambio)
Anti-PD-1 hIgG4 Reference Antibody(Tislbio) Anti-PD1-IL2v Fusion hIgG1 Antibody(2149) Anti-PD1-IL2v Fusion hIgG1 Antibody(KY-0118)
Anti-PD-L1 hIgG1 Reference Antibody(Avebio) Anti-PDL1 hIgG4 Reference Antibody(Adebio) Anti-PD-L2 hIgG1 Antibody(Hz25G4-1.1)
Anti-VEGF×PD1 hIgG1 Reference Antibody (Ivobio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (Pumibio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (pumitamig)
Biotinylated Human PD1 Protein; His-Avi Tag Biotinylated Human PDL1 Protein; His-Avi Tag Canine PD1 Protein; hFc Tag
Cynomolgus PDL1 Protein; His Tag Human PD1 Protein; hFc Tag Human PD1 Protein; His Tag
Human PDL1 Protein; His Tag Human PDL1 Protein; mFc Tag Human PDL2 Protein; mFc Tag
Mouse PDL1 Protein; His Tag    
Message consultation
reset
submit
Message
Message consultation
reset
submit